Christina Condon Selected Research

LM11A-31

1/2018	TSPO-PET imaging using [18F]PBR06 is a potential translatable biomarker for treatment response in Huntington's disease: preclinical evidence with the p75NTR ligand LM11A-31.
1/2017	[18F]GE-180 PET Detects Reduced Microglia Activation After LM11A-31 Therapy in a Mouse Model of Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christina Condon Research Topics

Disease

3	Huntington Disease (Huntington's Disease) 01/2018 - 11/2013
2	Stroke (Strokes) 03/2020 - 01/2016
2	Disease Progression 01/2018 - 11/2016
2	Inflammation (Inflammations) 11/2016 - 11/2013
1	Dyspnea (Shortness of Breath) 11/2020
1	Neuroinflammatory Diseases 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Transient Ischemic Attack 01/2016
1	Multiple Chronic Conditions 01/2016

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 01/2018 - 11/2013
2	LM11A-31IBA 01/2018 - 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 11/2016
1	trans-sodium crocetinate (crocetin)IBA 01/2016
1	ParvalbuminsIBA 11/2013
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 11/2013

Therapy/Procedure

1	Exercise Therapy (Therapy, Exercise) 11/2020
1	Subacute Care 03/2020
1	Transitional Care 03/2020
1	Ambulatory Care (Outpatient Care) 03/2020
1	Oral Administration 01/2018
1	Therapeutics 01/2017